Advanced diagnostic kit developed for detecting highly pathogenic H5N1 avian influenza virus

The Diagnostics Development Hub (DxD Hub), a national platform hosted by the Agency for Science, Technology and Research (A*STAR), Singapore, in collaboration with the National Institute for Environmental Studies (NIES), Japan, and the A*STAR Bioinformatics Institute (A*STAR BII), has successfully developed Steadfast, an advanced diagnostic kit for detecting the highly pathogenic H5N1 Avian Influenza Virus (AIV).

Mpox vaccine collab; $11M oncology seed; Gates backs RSV vaccine; Kyowa Kirin slims portfolio

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 27, 2024

Lawmakers want FTC to probe big PBMs over private-label biosimilar deals

A pair of U.S. lawmakers is urging the Federal Trade Commission to investigate the parent companies of two large pharmacy benefit managers over concerns that

October 2, 2024

Cancer drug shortages, subsequent price hikes remain a dark cloud over patient care centers

A vast majority of cancer centers are still grappling with generic drug shortages, according to a survey by the National Comprehensive Cancer Network (NCCN). Facilities

October 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.